Alcohol Implant (Disulfiram, “Esperal”) and Alcohol Use Disorder: Does It Treat Alcoholism?
An alcohol implant commonly referred to as “Esperal” (disulfiram) is an aversive medication used in selected patients with alcohol use disorder. It may support abstinence in specific circumstances, but it does not treat the underlying causes of addiction and should not be viewed as a stand-alone therapy.
What is “Esperal” (disulfiram)?
“Esperal” is a historical brand name for disulfiram, introduced in the 1950s as part of aversion-based treatment for alcohol dependence. Although the brand name is no longer used in many countries, in everyday language it still refers to disulfiram implantation or other long-acting forms of this medication.
Disulfiram does not reduce alcohol craving and does not change the core mechanisms of addiction. Its effect is based on triggering a strongly unpleasant physiological reaction after alcohol exposure, which is intended to discourage drinking.
How does disulfiram work?
ethanol -> acetaldehyde
acetaldehyde -> acetic acid (with the enzyme aldehyde dehydrogenase)
Disulfiram inhibits aldehyde dehydrogenase, leading to accumulation of acetaldehyde after alcohol exposure. Elevated acetaldehyde levels are responsible for the disulfiram-alcohol reaction, which can begin within minutes after contact with alcohol.
The term “Esperal” is colloquial and historical. In clinical practice, the medication used is disulfiram, which is the active substance in an alcohol implant. On this page we use the term “Esperal” only because it remains common in patient language.
Disulfiram-alcohol reaction
The reaction can involve rapid onset of symptoms such as:
nausea and vomiting
intense anxiety and fear
palpitations, tachycardia
chest tightness or chest pain
shortness of breath
dizziness
blood pressure fluctuations
In severe cases, serious medical complications may occur, including:
cardiac rhythm disturbances
seizures
stroke
respiratory depression
loss of consciousness
life-threatening events
For this reason, disulfiram can be used only after medical qualification and with full informed consent from the patient.
What is the aversive effect of disulfiram?
Alcohol is often associated with short-term relief or pleasure, while negative consequences are delayed. Disulfiram reverses this pattern by producing an immediate, strongly negative physical reaction after alcohol exposure.
As a result, alcohol may stop being associated with reward and become linked to fear and discomfort. In some patients, this may support behavioural avoidance of alcohol, particularly during early abstinence.
Does “Esperal” treat alcoholism?
No. Disulfiram does not treat alcoholism or alcohol use disorder.
Disulfiram:
does not remove psychological dependence
does not reduce alcohol craving
does not change coping mechanisms for stress
does not treat trauma or co-occurring mental health conditions
Its role is limited to temporary support of abstinence through an aversive mechanism. Long-term recovery from alcohol dependence requires comprehensive care, typically including psychotherapy, psychiatric support when indicated, and relapse prevention planning.
Disulfiram implantation procedure
When an implant form is used, disulfiram is placed subcutaneously during a minor surgical procedure performed by a physician under local anesthesia.
Clinical aspects may include:
procedure duration approximately 20 to 30 minutes
sterile conditions
wound care recommendations
duration of effect from several months up to about one year (depending on the preparation)
The procedure should be preceded by full medical assessment and qualification.
Alcohol and disulfiram: safety considerations
After disulfiram use, exposure to alcohol is strictly contraindicated, including:
alcoholic beverages (including beer and wine)
medications containing alcohol (for example syrups)
foods containing alcohol (sauces, wine vinegar, kombucha)
cosmetics and disinfectants containing alcohol
The patient must be clearly informed about all potential sources of exposure.
Clinical Contact
Contact with the center is intended for providing information regarding inpatient treatment and coordinating next steps in a confidential and non-binding manner.
Potential benefits and clinical limitations of an alcohol implant
Potential benefits
continuous pharmacological effect
no need for daily dosing
reduced risk of non-adherence
possible support during early abstinence
Clinical limitations
does not treat the causes of addiction
does not reduce alcohol craving
carries risk of severe reactions after alcohol exposure
effectiveness depends on patient motivation and parallel therapy
Disulfiram should be considered only as an adjunct element of alcohol use disorder treatment.
The role of disulfiram within comprehensive alcohol treatment
In selected cases, disulfiram may be included in a broader treatment plan that may involve:
medically supervised detoxification when indicated
individual psychotherapy
psychiatric care when indicated
relapse prevention planning
long-term therapeutic support
The decision to use disulfiram should always be individualized and based on medical assessment.
Possible local complications after disulfiram implantation
Even when the implantation procedure is performed correctly, a small proportion of patients may develop local reactions related to individual immune response or sensitivity to the implant material.
Possible complications may include:
allergic reaction to disulfiram or implant components
local inflammation
pain, redness, or swelling at the implantation site
purulent discharge or wound leakage
delayed tissue healing
In rare cases, bacterial infection may occur and require medical intervention.
When should you seek urgent medical attention?
The patient should contact the clinical team immediately if any of the following occur after the procedure:
increasing pain at the implantation site
purulent discharge or unpleasant odor from the wound
persistent redness or warmth of the skin
fever or systemic signs of infection
symptoms suggesting an allergic reaction
In these situations, patients should not attempt self-treatment and should not try to remove the implant without medical consultation.
Contact with the treatment center allows clinical assessment and appropriate management.
Who may be considered for disulfiram
Disulfiram may be considered as part of treatment in patients who:
understand the mechanism of action and provide voluntary informed consent
are abstinent at the time of qualification
are motivated to remain abstinent and view the medication as support, not a “guarantee”
are participating in or planning to participate in addiction psychotherapy
require additional behavioural support during early abstinence
have no medical contraindications to disulfiram
understand the need to avoid alcohol in any form
Who is not an appropriate candidate for disulfiram
Disulfiram is not an appropriate option if:
the patient treats the implant as a substitute for therapy or as “treatment for alcoholism”
there are liver disease, cardiac conditions, or other medical contraindications
there is no full awareness of risks and no informed consent
the patient continues drinking or is not ready for abstinence
severe mental health conditions require a different level of care
parallel psychotherapy cannot be ensured
there is high risk of non-adherence to safety recommendations
The use of disulfiram should always be an individual decision, preceded by medical qualification and integrated into a comprehensive alcohol treatment plan.
Comprehensive alcohol use disorder treatment
CLINICAL INQUIRY
The form is intended for submitting a clinical inquiry. Messages are delivered directly to the team responsible for treatment coordination.
FAQ - Alcohol implant / “Esperal”
No. Disulfiram does not treat alcoholism. It may only support abstinence through an aversive mechanism.
It may be used safely only under medical supervision. Alcohol exposure during treatment can be dangerous.
Depending on the preparation and the individual, effects may last from about 8 months up to around one year.
It is not intended for self-removal. Any intervention requires a physician’s decision.
Yes. Without psychological and psychiatric support, relapse risk remains high.
People with medical contraindications, lack of informed consent, or inability to follow safety requirements.
Important medical information and treatment limitations
Disulfiram use, including implantation, involves potential medical risk even when the procedure is performed according to clinical standards.
Individual response to the medication:
may vary and can be difficult to predict
does not always depend on procedural technique
may include systemic and local adverse effects
Disulfiram does not guarantee abstinence, does not eliminate relapse risk, and does not replace psychotherapy or psychiatric treatment.
Each patient should be clearly informed about:
the medication’s mechanism of action
possible complications
the need to strictly avoid alcohol
limitations of effectiveness
The decision to use disulfiram should be made only after individual medical qualification.
Medical and educational disclaimer
The information on this page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or a therapeutic recommendation and cannot replace an individual consultation with a physician or another qualified healthcare professional.
Treatment of alcohol use disorder and the use of medications such as disulfiram require an individual clinical assessment that considers the patient’s health status, medical history, and potential contraindications.
Therapeutic decisions should be made exclusively by licensed medical professionals.
Empathy, Confidentiality, and Clinical Safety
The treatment process is conducted under conditions of full confidentiality, with respect for patient dignity and individual needs.
The discreet setting of the facility and the continuous presence of the medical team ensure a sense of safety, stabilization, and anonymity at every stage of treatment.
Scope of Treatment and Clinical Responsibility
Inpatient treatment provided at Zeus Detox & Rehab focuses on medical stabilization, psychiatric evaluation, and intensive therapeutic intervention during the acute or advanced phase of a disorder.
Inpatient care does not replace long-term outpatient treatment, does not constitute a guarantee of specific clinical outcomes, and requires individual medical qualification. Planning of continued care, treatment continuity, and structured post-discharge support forms an integral part of the therapeutic process.
The scope and structure of treatment are determined individually by the clinical team based on the patient’s current medical and psychiatric condition, formal diagnosis, and applicable clinical standards. The content presented on this website is not intended for self-directed treatment decisions and does not substitute direct consultation with a licensed medical professional.
Medical and Educational Disclaimer
The information provided on this website is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment and cannot replace an individual consultation with a physician or other qualified healthcare professional.
Addiction treatment and mental health care require individualized clinical assessment. Therapeutic decisions must be made exclusively by licensed healthcare professionals based on a comprehensive evaluation of the patient’s condition. The described treatment model refers to clinical practice conducted in Poland, in accordance with applicable medical regulations and standards.
Content Author
Medical Content Review
Clinical Responsibility
Last medical review: 02/2026